U.S. Gene Synthesis Market Size, Share & Trends Analysis Report By Methods (Solid-phase Synthesis, Chip-based Synthesis), By Services (Antibody DNA Synthesis, Viral DNA Synthesis), By Application, By End-use, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                       1.1.1. Method
                       1.1.2. Services
                       1.1.3. Application
                       1.1.4. End Use
                       1.1.5. Estimates and forecast timeline
                   1.2. Research Methodology
                   1.3. Information Procurement
                       1.3.1. Purchased database
                       1.3.2. GVR’s internal database
                       1.3.3. Secondary sources
                       1.3.4. Primary research
                       1.3.5. Details of primary research
                   1.4. Information or Data Analysis
                       1.4.1. Data analysis models
                   1.5. Market Formulation & Validation
                   1.6. Model Details
                       1.6.1. Commodity flow analysis (Model 1)
                           1.6.1.1. Approach 1: Commodity flow approach
                       1.6.2. Volume price analysis (Model 2)
                           1.6.2.1. Approach 2: Volume price analysis
                   1.7. List of Secondary Sources
                   1.8. List of Primary Sources
                   1.9. Objectives
                       1.9.1. Objective 1
                       1.9.2. Objective 2
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Method outlook
                       2.2.2. Services outlook
                       2.2.3. Application outlook
                       2.2.4. End use outlook
                   2.3. Competitive Insights
Chapter 3. Gene Synthesis Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Penetration & Growth Prospect Mapping
                   3.3. Industry Value Chain Analysis
                       3.3.1. Reimbursement framework
                   3.4. Market Dynamics
                       3.4.1. Market driver analysis
                           3.4.1.1. Rising investments in synthetic biology
                           3.4.1.2. Advent of enzymatic DNA synthesis process
                           3.4.1.3. Technological advancements in the DNA synthesis platforms
                           3.4.1.4. Declining price of DNA synthesis & sequencing
                       3.4.2. Market restraint analysis
                           3.4.2.1. Lack of skilled professionals
                           3.4.2.2. Misuse of gene synthesis
                   3.5. U.S. Gene Synthesis Market Analysis Tools
                       3.5.1. Industry Analysis - Porter’s Five Forces
                           3.5.1.1. Supplier power
                           3.5.1.2. Buyer power
                           3.5.1.3. Substitution threat
                           3.5.1.4. Threat of new entrant
                           3.5.1.5. Competitive rivalry
                       3.5.2. PESTEL Analysis
                           3.5.2.1. Political landscape
                           3.5.2.2. Technological landscape
                           3.5.2.3. Economic landscape
                       3.5.3. Major Deals & Strategic Alliances Analysis
                       3.5.4. Market Entry Strategies
Chapter 4. U.S. Gene Synthesis Market: Method Estimates & Trend Analysis
                   4.1. Methods Market Share, 2023 & 2030
                   4.2. Segment Dashboard
                   4.3. U.S. Gene Synthesis Market by Method Outlook
                   4.4. U.S. Market Size & Forecasts and Trend Analyses, 2018 to 2030
                       4.4.1. Solid-phase Synthesis
                           4.4.1.1. Solid-phase Synthesis market estimates and forecast 2018 to 2030 (USD Million)
                       4.4.2. Chip-based Synthesis
                           4.4.2.1. Chip-based Synthesis market estimates and forecast 2018 to 2030 (USD Million)
                       4.4.3. PCR-based Enzyme Synthesis
                           4.4.3.1. PCR-based Enzyme Synthesis market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. U.S. Gene Synthesis Market: Services Estimates & Trend Analysis
                   5.1. Services Market Share, 2023 & 2030
                   5.2. Segment Dashboard
                   5.3. U.S. Gene Synthesis Market by Services Outlook
                   5.4. U.S. Market Size & Forecasts and Trend Analyses, 2018 to 2030
                       5.4.1. Antibody DNA Synthesis
                           5.4.1.1. Antibody DNA synthesis estimates and forecast 2018 to 2030 (USD Million)
                       5.4.2. Viral DNA Synthesis
                           5.4.2.1. Viral DNA synthesis estimates and forecast 2018 to 2030 (USD Million)
                       5.4.3. Others
                           5.4.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. U.S. Gene Synthesis Market: Application Estimates & Trend Analysis
                   6.1. Application Market Share, 2023 & 2030
                   6.2. Segment Dashboard
                   6.3. U.S. Gene Synthesis Market by Application Outlook
                   6.4. U.S. Market Size & Forecasts and Trend Analyses, 2018 to 2030
                       6.4.1. Gene & Cell Therapy Development
                           6.4.1.1. Gene &cell therapy development estimates and forecast 2018 to 2030 (USD Million)
                       6.4.2. Vaccine Development
                           6.4.2.1. Vaccine development estimates and forecast 2018 to 2030 (USD Million)
                       6.4.3. Disease Diagnosis
                           6.4.3.1. Disease Diagnosis market estimates and forecast 2018 to 2030 (USD Million)
                       6.4.4. Others
                           6.4.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. U.S. Gene Synthesis Market: End Use Estimates & Trend Analysis
                   7.1. End Use Market Share, 2023 & 2030
                   7.2. Segment Dashboard
                   7.3. U.S. Gene Synthesis Market by End Use Outlook
                   7.4. U.S. Market Size & Forecasts and Trend Analyses, 2018 to 2030
                       7.4.1. Biotechnology and Pharmaceutical Companies
                           7.4.1.1. Biotechnology and pharmaceutical companies estimates and forecast 2018 to 2030 (USD Million)
                       7.4.2. Academic and Government Research Institutes
                           7.4.2.1. Academic and government research institutes market estimates and forecast 2018 to 2030 (USD Million)
                       7.4.3. Contract Research Organization (CRO)
                           7.4.3.1. Contract research organization (CRO) market estimates and forecast 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
                   8.1. Recent Developments & Impact Analysis, By Key Market Participants
                   8.2. Company/Competition Categorization
                       8.2.1. Innovators
                   8.3. Vendor Landscape
                       8.3.1. List of key distributors and channel partners
                       8.3.2. Key customers
                       8.3.3. Key company market share analysis, 2023
                       8.3.4. GenScript
                           8.3.4.1. Company overview
                           8.3.4.2. Financial performance
                           8.3.4.3. Product benchmarking
                           8.3.4.4. Strategic initiatives
                       8.3.5. Brooks Automation, Inc. (GENEWIZ)
                           8.3.5.1. Company overview
                           8.3.5.2. Financial performance
                           8.3.5.3. Product benchmarking
                           8.3.5.4. Strategic initiatives
                       8.3.6. Boster Biological Technology
                           8.3.6.1. Company overview
                           8.3.6.2. Financial performance
                           8.3.6.3. Product benchmarking
                           8.3.6.4. Strategic initiatives
                       8.3.7. Twist Bioscience
                           8.3.7.1. Company overview
                           8.3.7.2. Financial performance
                           8.3.7.3. Product benchmarking
                           8.3.7.4. Strategic initiatives
                       8.3.8. ProteoGenix, Inc
                           8.3.8.1. Company overview
                           8.3.8.2. Financial performance
                           8.3.8.3. Product benchmarking
                           8.3.8.4. Strategic initiatives
                       8.3.9. Biomatik
                           8.3.9.1. Company overview
                           8.3.9.2. Financial performance
                           8.3.9.3. Product benchmarking
                           8.3.9.4. Strategic initiatives
                       8.3.10. ProMab Biotechnologies, Inc.
                           8.3.10.1. Company overview
                           8.3.10.2. Financial performance
                           8.3.10.3. Product benchmarking
                           8.3.10.4. Strategic initiatives
                       8.3.11. Thermo Fisher Scientific, Inc.
                           8.3.11.1. Company overview
                           8.3.11.2. Financial performance
                           8.3.11.3. Product benchmarking
                           8.3.11.4. Strategic initiatives
                       8.3.12. Integrated DNA Technologies, Inc.
                           8.3.12.1. Company overview
                           8.3.12.2. Financial performance
                           8.3.12.3. Product benchmarking
                           8.3.12.4. Strategic initiatives
                       8.3.13. OriGene Technologies, Inc.
                           8.3.13.1. Company overview
                           8.3.13.2. Financial performance
                           8.3.13.3. Product benchmarking
                           8.3.13.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 U.S. gene synthesis market, by method, 2018 - 2030 (USD Million)
Table 3 U.S. gene synthesis market, by services, 2018 - 2030 (USD Million)
Table 4 U.S. gene synthesis market, by application, 2018 - 2030 (USD Million)
Table 5 U.S. gene synthesis market, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 gene synthesis market: market outlook
Fig. 9 gene synthesis market competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 U.S. Gene synthesis market driver impact
Fig. 15 U.S. Gene synthesis market restraint impact
Fig. 16 U.S. Gene synthesis market strategic initiatives analysis
Fig. 17 U.S. Gene synthesis market: Method movement analysis
Fig. 18 U.S. Gene synthesis market: Method outlook and key takeaways
Fig. 19 Solid-phase synthesis market estimates and forecast, 2018 - 2030
Fig. 20 Chip-based synthesis market estimates and forecast, 2018 - 2030
Fig. 21 PCR-based enzyme synthesis market estimates and forecast, 2018 - 2030
Fig. 22 U.S. Gene synthesis market: Services movement analysis
Fig. 23 U.S. Gene synthesis market: Services outlook and key takeaways
Fig. 24 Antibody DNA synthesis market estimates and forecast, 2018 - 2030
Fig. 25 Viral DNA synthesis market estimates and forecast, 2018 - 2030
Fig. 26 Others market estimates and forecast, 2018 - 2030
Fig. 27 U.S. Gene synthesis market: Application movement analysis
Fig. 28 U.S. Gene synthesis market: Application outlook and key takeaways
Fig. 29 Gene & Cell Therapy Development market estimates and forecast, 2018 - 2030
Fig. 30 Vaccine Development market estimates and forecast, 2018 - 2030
Fig. 31 Disease Diagnosis market estimates and forecast, 2018 - 2030
Fig. 32 Others market estimates and forecast, 2018 - 2030
Fig. 33 U.S. Gene synthesis market: End use movement analysis
Fig. 34 U.S. Gene synthesis market: End use outlook and key takeaways
Fig. 35 Biotechnology and Pharmaceutical companies market estimates and forecast, 2018 - 2030
Fig. 36 Academic and government research institutes market estimates and forecast, 2018 - 2030
Fig. 37 Contract research organizations (CROs) market estimates and forecast, 2018 - 2030
Fig. 38 Participant categorization- U.S. gene synthesis market
Fig. 39 Market share of key market players- U.S. gene synthesis market